【阿里巴巴与世卫组织携手，全球推广AI癌症筛查技术】
近期，阿里巴巴与世界卫生组织（WHO）在瑞士日内瓦举办的AI for Good全球峰会上达成战略合作，共同推动阿里巴巴达摩院的AI癌症筛查技术在全球范围内的应用。此次合作旨在通过先进的人工智能技术，提高癌症筛查的效率和准确性，从而在全球范围内实现早期发现、早期治疗，以降低癌症带来的健康威胁。
阿里巴巴在此次峰会上宣布，其内部研发的AI癌症早筛技术已在国内成功为超过600万人次提供了服务，覆盖了胰腺癌、食管癌、肠癌、胃癌、肝肿瘤等多种病症的筛查。这一技术通过深度学习算法对医学影像进行分析，能够有效提高癌症诊断的准确性和速度，显著降低了误诊率，为患者争取到了宝贵的治疗时间。
此外，阿里巴巴与世卫组织的合作还得到了国际认可，已与安提瓜和巴布达卫生部达成战略合作，将AI癌症筛查技术引入到这些国家的公共卫生体系中。这标志着阿里巴巴的AI技术在国际医疗健康领域迈出了重要一步，为全球癌症防控提供了新的解决方案。
阿里巴巴集团表示，此次与世卫组织的合作，不仅体现了阿里巴巴在AI技术研发上的实力，更彰显了其在全球公共卫生领域的责任与担当。阿里巴巴将与世卫组织紧密合作，持续优化AI癌症筛查技术，让更多国家和地区的民众受益，共同构建一个更加健康、安全的世界。
英语如下：
Headline: “Alibaba Teams Up with WHO to Globally Promote AI Cancer Screening Technology”
Keywords: Alibaba, WHO, AI cancer screening
Content: “Alibaba and the WHO Join Forces to Globally Promote AI Cancer Screening Technology”
In a strategic collaboration unveiled at the AI for Good Global Summit in Geneva, Switzerland, Alibaba and the World Health Organization (WHO) have partnered to advance the application of Alibaba DAMO Academy’s AI cancer screening technology across the globe. This partnership aims to leverage cutting-edge AI technology to enhance the efficiency and accuracy of cancer screening, thereby enabling early detection and treatment to mitigate the health impacts of cancer worldwide.
At the summit, Alibaba announced that its internally developed AI cancer early screening technology has successfully provided services to over 6 million people in China, covering the screening of various diseases including pancreatic cancer, esophageal cancer, colorectal cancer, gastric cancer, and liver tumors. This technology, powered by deep learning algorithms, analyzes medical images to significantly boost the accuracy and speed of cancer diagnosis, drastically reducing misdiagnosis rates and securing valuable treatment time for patients.
Furthermore, Alibaba’s collaboration with the WHO has received international recognition, culminating in a strategic partnership with the Ministry of Health of Antigua and Barbuda, where the AI cancer screening technology is being integrated into their public health systems. This signifies a significant step forward for Alibaba’s AI technology in the international healthcare sector, offering new solutions for global cancer prevention and control.
Alibaba Group stated that this collaboration with the WHO not only highlights Alibaba’s prowess in AI technology development but also underscores its commitment and responsibility in the global public health domain. Alibaba will work closely with the WHO to continuously refine the AI cancer screening technology, benefiting more countries and regions, and together building a healthier and safer world.
【来源】https://www.ithome.com/0/772/385.htm
Views: 0